Literature DB >> 9649211

Analysis of orbital T cells in thyroid-associated ophthalmopathy.

G Förster1, E Otto, C Hansen, K Ochs, G Kahaly.   

Abstract

Thyroid-associated ophthalmopathy (TAO) has a major effect on the two compartments of the retro-orbital (RO) space, leading to enlargement of the extraocular muscles and other RO tissues. T lymphocyte infiltration of RO tissue is a characteristic feature of TAO and there is current interest in whether these T cells are specifically and selectively reactive to RO tissue itself. We recently established 18 T cell lines (TCL) from RO adipose/connective tissue of six patients with severe TAO by using IL-2, anti-CD3 antibodies and irradiated autologous peripheral blood mononuclear cells (PBMC) to maintain the growth of T cells reactive to autologous RO tissue protein fractions. Here we report on the phenotype characteristics and cytokine gene expression profiles of these orbital TCL and on their immunoreactivity to the organ-specific thyroid antigens thyrotropin receptor (TSH-R), thyroidal peroxidase (TPO) and thyroglobulin (TG). Flow cytometry revealed that 10 TCL were predominantly of CD4+ phenotype, three being mostly CD8+ and five neither CD4+ nor CD8+. Analysis with reverse transcriptase-polymerase chain reaction (RT-PCR) of cytokine gene expression revealed both Th1- and Th2-like products in all TCL: IL-2 product (in 17 TCL), interferon-gamma (IFN-gamma) (n = 10), tumour necrosis factor-beta (TNF-beta) (n = 15), IL-4 (n = 12), IL-5 (n = 17), IL-6 (n = 13), TNF-alpha (n = 12) and IL-10 (n = 4). Reactivity to thyroid antigens was observed only in two TCL, the other 16 being uniformly unreactive. Although 10 out of 18 RO tissue-reactive TCL were predominantly CD4+ there were no significant relationships between TCL phenotype, cytokine gene profile, magnitude of reactivity to RO tissue protein or the (rare) occurrence of thyroid reactivity. The findings of both Th1- and Th2-like cytokine gene expression in all RO tissue-reactive TCL support the concept that TAO is a tissue-specific autoimmune disease, distinct immunologically from the thyroid, and involving both T cell and B cell autoimmune mechanisms in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649211      PMCID: PMC1904994          DOI: 10.1046/j.1365-2249.1998.00613.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO).

Authors:  A Pappa; V Calder; R Ajjan; P Fells; M Ludgate; A P Weetman; S Lightman
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

2.  Direct blotting with viable cells of protein mixtures separated by two-dimensional gel electrophoresis.

Authors:  H Gulle; B Schoel; S H Kaufmann
Journal:  J Immunol Methods       Date:  1990-10-19       Impact factor: 2.303

3.  Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines.

Authors:  G Aust; M Heuer; S Laue; I Lehmann; A Hofmann; N E Heldin; W A Scherbaum
Journal:  Clin Exp Immunol       Date:  1996-07       Impact factor: 4.330

4.  Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis.

Authors:  D B Corry; N M Ampel; L Christian; R M Locksley; J N Galgiani
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

5.  Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.

Authors:  E A Otto; K Ochs; C Hansen; J R Wall; G J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

6.  Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.

Authors:  A P Weetman; S Cohen; K C Gatter; P Fells; B Shine
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

7.  Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells.

Authors:  C A Brenner; A W Tam; P A Nelson; E G Engleman; N Suzuki; K E Fry; J W Larrick
Journal:  Biotechniques       Date:  1989 Nov-Dec       Impact factor: 1.993

8.  Induction of TH1 and TH2 immunity in neonatal mice.

Authors:  T Forsthuber; H C Yip; P V Lehmann
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

9.  Efficient propagation and cloning of human T cells in the absence of antigen by means of OKT3, interleukin 2, and antigen-presenting cells.

Authors:  M Londei; B Grubeck-Loebenstein; P de Berardinis; C Greenall; M Feldmann
Journal:  Scand J Immunol       Date:  1988-01       Impact factor: 3.487

10.  Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy.

Authors:  G H Tan; C M Dutton; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

View more
  20 in total

Review 1.  New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.

Authors:  R A Ajjan; A P Weetman
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 3.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

Review 4.  Immunopathogenesis of thyroid eye disease: emerging paradigms.

Authors:  Vibhavari M Naik; Milind N Naik; Robert A Goldberg; Terry J Smith; Raymond S Douglas
Journal:  Surv Ophthalmol       Date:  2010 May-Jun       Impact factor: 6.048

5.  Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.

Authors:  A Boschi; Ch Daumerie; M Spiritus; C Beguin; M Senou; D Yuksel; M Duplicy; S Costagliola; M Ludgate; M C Many
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 6.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

7.  A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.

Authors:  Seema Kumar; Reagan Schiefer; Michael J Coenen; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

8.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

Review 9.  Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment.

Authors:  Sita Virakul; Leendert van Steensel; Virgil A S H Dalm; Dion Paridaens; P Martin van Hagen; Willem A Dik
Journal:  Eur Thyroid J       Date:  2014-12-06

Review 10.  [Endocrine orbitopathy 1998].

Authors:  G Förster; G Kahaly
Journal:  Med Klin (Munich)       Date:  1998-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.